Interstitial lung disease (ILD) is a frequent pulmonary manifestation and an important cause
of morbidity and mortality in patients with idiopathic inflammatory myopathy. Myositis-related …

Objective Interstitial lung disease (ILD) is the most severe complication of idiopathic
inflammatory myositis (IIM), resulting in significant increase in morbidity and mortality and for …

Inflammatory myopathies are heterogeneous clinico-serological syndromes, with variable
clinical manifestations. Interstitial lung disease (ILD) is a major cause of morbidity and …

Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and
clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases …

Despite the lack of placebo-controlled trials, glucocorticoids are considered the mainstay of
initial treatment for idiopathic inflammatory myopathy and myositis-associated interstitial …

Inflammatory myopathies (IM) are auto-immune connective tissue diseases characterized by
muscle involvement and by extramuscular manifestations. As such, pulmonary …

Although interstitial lung disease (ILD) is a leading cause of morbidity and mortality in
patients with inflammatory myopathies, the current definition and diagnostic criteria of …

The idiopathic inflammatory myopathies (IIMs) affect more than 60,000 individuals in the
United States and an estimated 770,000 worldwide. 1 Although widely considered a disease …

Idiopathic inflammatory myopathies are autoimmune processes that are characterized by
skeletal muscle inflammation. The lung is the most commonly involved extramuscular organ …

Objective Idiopathic inflammatory myopathy (IIM)–associated interstitial lung disease (ILD)
can range from rapidly progressive disease with high mortality to indolent disease with …